You have 9 free searches left this month | for more free features.

M3814

Showing 1 - 25 of 84

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • (no location specified)
Jan 14, 2023

Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

Recruiting
  • Neuroendocrine Neoplasm
  • Biospecimen Collection
  • +4 more
  • Duarte, California
  • +3 more
Jan 12, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022

Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Hypofractionated Radiation Therapy
  • +2 more
  • Duarte, California
  • +29 more
Apr 2, 2022

Advanced Solid Tumors Trial in Worldwide (MSC2490484A (M3814), Fractionated RT, Cisplatin)

Completed
  • Advanced Solid Tumors
  • MSC2490484A (M3814)
  • +2 more
  • Fresno, California
  • +25 more
Apr 6, 2022

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Healthy Trial in Gauting, Neu-Ulm (Peposertib)

Completed
  • Healthy
  • Gauting, Germany
  • +1 more
May 11, 2021

Locally Advanced Rectal Cancer Trial in Spain, United States (Peposertib 50 mg, Peposertib 100 mg, Peposertib 150 mg)

Completed
  • Locally Advanced Rectal Cancer
  • Peposertib 50 mg
  • +5 more
  • Aurora, Colorado
  • +13 more
Jun 9, 2022

Advanced Solid Tumors, Chronic Lymphocytic Leukemia Trial in Belgium, Denmark, Netherlands (MSC2490484A (M3814))

Completed
  • Advanced Solid Tumors
  • Chronic Lymphocytic Leukemia
  • MSC2490484A (M3814)
  • Bruxelles, Belgium
  • +6 more
Apr 24, 2020

Small Cell Lung Cancer Trial in Worldwide (M3814, Cisplatin, Etoposide)

Terminated
  • Small Cell Lung Cancer
  • M3814
  • +2 more
  • Mesa, Arizona
  • +79 more
Sep 11, 2020

HIV Trial in Worldwide (GSK3640254, ABC/3TC, FTC/TAF)

Active, not recruiting
  • HIV Infections
  • Los Angeles, California
  • +65 more
Jul 18, 2022

Post-herpetic Neuralgia Trial in Worldwide (EMA401, Placebo)

Terminated
  • Post-herpetic Neuralgia
  • Melbourne, Victoria, Australia
  • +57 more
Oct 7, 2021

Arthritis, Psoriatic Trial in Worldwide (Guselkumab 100 mg, Placebo)

Completed
  • Arthritis, Psoriatic
  • Guselkumab 100 mg
  • Placebo
  • Brussels, Belgium
  • +116 more
Nov 29, 2021

Nasal Polyps, Chronic Rhinosinusitis Trial in Worldwide (Omalizumab, Placebo)

Completed
  • Nasal Polyps
  • Chronic Rhinosinusitis
  • Birmingham, Alabama
  • +78 more
Mar 31, 2022

Non Cystic Fibrosis Bronchiectasis Trial in Worldwide (Colistimethate Sodium, Saline Solution)

Completed
  • Non Cystic Fibrosis Bronchiectasis
  • Colistimethate Sodium
  • Saline Solution
  • Adelaide, Australia
  • +84 more
Aug 3, 2021

Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Birmingham, Alabama
  • +155 more
Aug 12, 2022

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Lung Diseases, Interstitial Trial in Worldwide (Pirfenidone, Placebo)

Completed
  • Lung Diseases, Interstitial
  • Camperdown, New South Wales, Australia
  • +65 more
Dec 22, 2020

Non Alcoholic Steatohepatitis (NASH) Trial in Worldwide (Obeticholic Acid, Placebo)

Active, not recruiting
  • Non Alcoholic Steatohepatitis (NASH)
  • Obeticholic Acid
  • Placebo
  • Birmingham, Alabama
  • +345 more
Jan 24, 2023

Multiple Sclerosis Trial in Worldwide (ponesimod, teriflunomide)

Completed
  • Multiple Sclerosis
  • Carlsbad, California
  • +161 more
Jan 24, 2022

Glomerular Disease, Proteinuria Trial in Australia, Georgia, United States (ANG-3070, Placebo)

Recruiting
  • Glomerular Disease
  • Proteinuria
  • Birmingham, Alabama
  • +29 more
Mar 22, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021